Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a "polypill" combination of three ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for ...

Baidu unveils a powerful open-source AI model that rivals Google and OpenAI in visual reasoning, multimodal analysis, and enterprise efficiency using just a fraction of computing power.

Q3 2025 Earnings Call Transcript November 10, 2025 Capricor Therapeutics, Inc. reports earnings inline with expectations.

The researchers discovered that this separation proves remarkably clean. In a preprint paper released in late October, they ...

Objective The left atrial stiffness index (LASI) has been proven to be a promising marker for assessing left atrial (LA) and ...

Positive topline data from Part B of the TX45 Phase 1b trial demonstrated improvements in both left heart function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart F ...

Yesterday at the Ernest N Morial Convention Center, latest clinical trial findings were disclosed on the use of human engineered heart muscle as biological ventricular assist tissue (BioVAT) ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...